Incidence and Survival Outcomes of Breast Cancer with Synchronous Hepatic Metastases: A Population-Based Study

Conclusion: In conclusion, patients with BCSHM had a poor survival, and only 13.5% of them were alive more than 3 years. Young patients with HER2+ tumors had higher risk for developing BCSHM, but with better prognosis.

Source: Journal of Cancer - December 14, 2018 Category: Cancer & Oncology Authors: Weikai Xiao, Shaoquan Zheng, Anli Yang, Xingcai Zhang, Peng Liu, Xinhua Xie, Hailin Tang, Xiaoming Xie Tags: Research Paper Source Type: research